4 hrs ago
FSSAI Orders Sale Halt After Nestle Whitener Sample Fails Test
India’s food safety regulator tested a sample of Nestle Low Fat Dairy Whitener.
The sample came from The Lalit hotel in New Delhi.
A laboratory said it was unsafe and did not meet food safety rules.
FSSAI sent a notice to the company that operates the hotel and shared the test report.
It also told the operator to stop selling the identified product.
The operator can appeal the laboratory’s findings within the time allowed by law.
The articles do not say whether an appeal has been filed.
One article also says Nestle denied separate earlier allegations about infant nutrition products.
FSSAI said a laboratory classified a sample of Nestle Low Fat Dairy Whitener as unsafe and substandard.
The sample was collected from Bharat Hotels Ltd’s The Lalit hotel in Connaught Place, New Delhi.
The regulator said the sample did not comply with the Food Safety and Standards Act, 2006.
FSSAI issued a notice to Bharat Hotels Ltd, shared the laboratory report, and directed the operator to stop sales of the identified product.
The hotel operator was given an opportunity to appeal; a separate report says Nestle has denied allegations in earlier cases involving infant nutrition products.
- Who
- The Food Safety and Standards Authority of India (FSSAI), Bharat Hotels Ltd, and Nestle India.
- What
- FSSAI reported that a laboratory classified a Nestle Low Fat Dairy Whitener sample as unsafe and substandard, issued a notice to Bharat Hotels Ltd, and ordered sales of the identified product to stop.
- Where
- The sample was collected at The Lalit hotel in Connaught Place, New Delhi.
- When
- FSSAI announced the finding on Saturday; the sample collection date is not specified.
- Why
- The food analyst’s laboratory report found the sample non-compliant with the Food Safety and Standards Act, 2006.
Regulator’s allegations
Nestle’s response in separate earlier cases
Infant nutrition product claims
Regulator’s allegations
FSSAI said claims involving NAN Excella Pro Stage 1 and Lactogen Pro 1 contravened rules on promotional claims for infant foods, and cited concerns about a follow-up formula’s nutritional parameters.
Nestle’s response in separate earlier cases
Nestle had rejected the allegations in those earlier cases, saying its products complied with applicable regulations and that the labels and claims had been approved and were supported by scientific literature.
Key facts
- Product
- Nestle Low Fat Dairy Whitener
- Laboratory finding
- Classified as unsafe and substandard
- Sample location
- The Lalit, Connaught Place, New Delhi
- Hotel operator
- Bharat Hotels Ltd
- Regulator
- Food Safety and Standards Authority of India (FSSAI)
- Regulatory action
- Notice issued to Bharat Hotels Ltd; immediate sale halt ordered for the identified product
- Appeal
- The operator was given an opportunity to appeal the Food Analyst’s report within the prescribed period
Quotes
FSSAI
India’s food safety regulator.
“In NAN Excella Pro Stage 1, claims relating to ‘5 HMOs’ and ‘Whey Protein’ were observed, while in Lactogen Pro 1, a claim relating to ‘Whey Protein’ being easy to digest was observed. Accordingly, clarifications were sought from M/s Nestlé India Limited regarding the above claims.”
livemint.com
“A sample of Nestlé "Low Fat Dairy Whitener" collected from M/s Bharat Hotels Ltd. (The Lalit), New Delhi, has been declared UNSAFE & SUBSTANDARD by Food Analyst reports under the FSS Act 2006.”
livemint.com
Sources
FSSAI issues notice to 'The Lalit' hotel operator over ‘unsafe’ Nestle product
Nestle Low Fat Dairy Whitener sale banned: Why FSSAI called it ‘unsafe, substandard’
FSSAI finds Nestle India's low-fat dairy whitener unsafe, substandard in Delhi five-star hotel sample
Nestle Low Fat Dairy Whitener found ‘unsafe, substandard’; FSSAI orders immediate sale ban
Related news
FSSAI Orders Halt After Nestlé Dairy Whitener Fails Quality Test
FSSAI Files Three Cases Against Nestlé India Infant Products
Maharashtra FDA Focuses Scrutiny On Infant Nutrition Products
Nestle India Denies FSSAI Baby Formula Legal Action Report
Maharashtra FDA Takes Action Against Suspected Substandard Milk Products
FSSAI Draft Bars Non-Milk Products From Using Paneer Name
